Effect of the Cycloergometer in Patients Undergoing Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
- Status
- TERMINATED
- Phase
- NA
COVID-19 Infection and Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Virtual Exercise for Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Isa-KRd vs KRd in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation (IsKia TRIAL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Personalized Autologous Transplant for Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
HA-1H TCR T Cell for Relapsed/Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplantation
- Status
- WITHDRAWN
- Phase
- PHASE1
Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Expanded Access for TNB-383B in a Subject With Relapsed/Refractory Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Digital Life Coaching for Myeloma Patients Undergoing Transplantation
- Status
- COMPLETED
- Phase
- NA
KRDI in Transplant-Eligible MM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory MM
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
- Status
- TERMINATED
- Phase
- PHASE1